Similar articles

• The effects of benzyl-imidazoline (priscol) in partially sympathectomized dogs.

  MARZONI FA, REARDON MJ, HENDRIX JP. MARZONI FA, et al. Fed Proc. 1947;6(1):355. Fed Proc. 1947. PMID: 20249600 No abstract available.
• The pharmacology of benzyl-imidazoline (Priscol).

  AHLQUIST RP, HUGGINS RA, WOODBURY RA. AHLQUIST RP, et al. J Pharmacol Exp Ther. 1947 Mar;89(3):271-88. J Pharmacol Exp Ther. 1947. PMID: 20290430 No abstract available.
• The effects of priscol (2-benzyl-4,5-imidazoline hydrochloride) in the treatment of peripheral vascular diseases.

  FRANK N, STRAZZA JA Jr, HELSPER JT. FRANK N, et al. Ann Intern Med. 1951 Jul;35(1):19-38. doi: 10.7326/0003-4819-35-1-19. Ann Intern Med. 1951. PMID: 14847446 No abstract available.
• Molecular aspects of the receptor activation by imidazolines: an overview.

  Patil PN, Feller DR, Miller DD. Patil PN, et al. J Neural Transm Suppl. 1991;34:187-94. doi: 10.1007/978-3-7091-9175-0_24. J Neural Transm Suppl. 1991. PMID: 1667871 Review.
• Imidazoline scaffold in medicinal chemistry: a patent review (2012-2015).

  Sączewski F, Kornicka A, Balewski Ł. Sączewski F, et al. Expert Opin Ther Pat. 2016 Sep;26(9):1031-48. doi: 10.1080/13543776.2016.1210128. Epub 2016 Jul 20. Expert Opin Ther Pat. 2016. PMID: 27382975 Review.